News Column

THE BIOTECH GROWTH TRUST PLC - Transaction in Own Shares

August 15, 2014

For immediate release 15 August 2014THE BIOTECH GROWTH TRUST PLC (the "Company") MARKET PURCHASE OF COMPANY'S OWN SHARES Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 10 July 2014 to make market purchases of the Company's own shares up to an aggregate maximum of 10,170,676 that a market total of 436,250 Ordinary shares of 25p each in the capital of the Company were purchased today by the Company at a price of 501.51p per share. These shares will be held in treasury. Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 4,248,241 and the total number of Ordinary shares that the Company has in issue is 68,886,347 so that the total number of voting rights in the Company following the repurchase is 64,638,106. The figure of 64,638,106 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules. For and on behalf of Frostrow Capital LLP Company Secretary For further information, please contact: Mark PopeFrostrow Capital LLP Tel: 020 3 008 4913

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: PR Newswire (UK Disclosure)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters